[HTML payload içeriği buraya]
32.3 C
Jakarta
Tuesday, May 12, 2026

Merck Companions with AMCM on 3D Printed Pill Manufacturing


Merck, a science and expertise firm, has introduced a cooperation settlement with AMCM, a German additive manufacturing firm and sister firm to EOS. The partnership focuses on growing 3D printing expertise for pill manufacturing that meets Good Manufacturing Apply (GMP) requirements for scientific trials, with plans to broaden to industrial manufacturing later.

Merck Partners with AMCM on 3D Printed Tablet ManufacturingMerck Partners with AMCM on 3D Printed Tablet Manufacturing
Credit score: Merck

The collaboration will use powder mattress fusion strategies, the place a laser melts and fuses powder supplies layer by layer to create tablets. This strategy goals to make lively pharmaceutical ingredient (API) formulation extra scalable whereas decreasing the necessity for expensive reformulations throughout drug improvement and manufacturing processes.

“Our partnership with AMCM / EOS has the potential to revolutionize the way in which tablets are produced. Will probably be a large transfer in the direction of digitalization of the business,” stated Isabel de Paoli, Chief Technique Officer at Merck. “Our purpose is to develop the commercial utility of this expertise, which we’ll make out there for scientific trials first, after which transfer to full digital options at industrial scale.”

Marie Langer, CEO of EOS, added, “We’re excited to assist Merck on its innovation journey. This cooperation combines Merck’s formulation competences in Healthcare in addition to its excipient experience in Life Science with our long-standing additive manufacturing know-how. Collectively, we’ll assist make drug improvement extra versatile and sooner.”

The businesses say the expertise might allow sooner and cheaper pill manufacturing. The long-term imaginative and prescient consists of versatile native pill manufacturing that may be tailored to particular market necessities and particular person affected person wants.

The venture is being developed at Merck’s Innovation Middle in Darmstadt, Germany, the place groups work on scaling concepts that create new enterprise alternatives throughout Merck’s Healthcare, Life Science, and Efficiency Supplies divisions.

Supply: merckgroup.com

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles